Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incretin hormones and type 2 diabetes
Michael A. Nauck, Timo D. Müller
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1780-1795
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Jingqian Su, Yingsheng Luo, Shan Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13381-13381
Open Access | Times Cited: 46
Role of lifestyle and glucagon‐like peptide‐1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases
Anna Giannakogeorgou, Michael Roden
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. S1
Open Access | Times Cited: 12
Recent advances in peptide-based therapies for obesity and type 2 diabetes
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2024) Vol. 173, pp. 171149-171149
Open Access | Times Cited: 11
Binding Kinetics, Bias, Receptor Internalization and Effects on Insulin Secretionin vitroandin vivoof a Novel GLP-1R/GIPR Dual Agonist, HISHS-2001
Yusman Manchanda, Ben Jones, Gaëlle Carrat, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Continuous glucose monitoring guides glucagon-like peptide 1-based therapy use and optimization in people with type 2 diabetes
Rita Parsiani, Thomas Grace, Courtney R. Green, et al.
Journal of Family Medicine and Primary Care (2025) Vol. 14, Iss. 2, pp. 790-795
Open Access | Times Cited: 1
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2025) Vol. 187, pp. 171380-171380
Open Access | Times Cited: 1
Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes
Riccardo Candido, Sara Gaiotti, Fabiola Giudici, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 6052-6052
Open Access | Times Cited: 17
Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management
Jang Won Son, Soo Lim
Endocrinology and Metabolism (2024) Vol. 39, Iss. 2, pp. 206-221
Open Access | Times Cited: 5
A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database
Liyuan Liu
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon‐like peptide‐1 receptor agonists in Japanese patients with type 2 diabetes mellitus
Shunichiro Tsukamoto, Shohei Tanaka, Takayuki Yamada, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 1, pp. 262-274
Closed Access | Times Cited: 11
Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
Dorte B. Zilstorff, Michael M. Richter, Jens Hannibal, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
Giovanni Targher, Alessandro Mantovani, Christopher D. Byrne, et al.
Gut (2024), pp. gutjnl-334023
Closed Access | Times Cited: 4
Nanostructure-Based Drug Delivery in Alleviating Type 2 Diabetes Mellitus
Annu Saini, Lokesh Nagar, Rohil Panwar, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access
Physiological Fatty Acid-Stimulated Insulin Secretion and Redox Signaling Versus Lipotoxicity
Petr Ježek
Antioxidants and Redox Signaling (2025)
Closed Access
Effects of GLP-1 receptor agonist therapy on resolution of steatohepatitis in non-alcoholic fatty liver disease: a systematic review and meta-analysis
Kathryn J. Potter, Jackie Phinney, Tasha Kulai, et al.
Journal of the Canadian Association of Gastroenterology (2025) Vol. 8, Iss. 2, pp. 47-57
Open Access
D’une longue pénurie thérapeutique au triomphe des nouvelles classes d’antidiabétiques dans des maladies non métaboliques
Serge Halimi
Médecine des Maladies Métaboliques (2025)
Closed Access
Risk of Retinal Vein Occlusion Between GLP-1 Receptor Agonists and DPP-4 Inhibitors in Type 2 Diabetes: A Retrospective Cohort Study
Ssu-Yu Pan, Chien‐Hsiang Weng, Shang-Feng Tsai, et al.
Ophthalmology Science (2025), pp. 100734-100734
Open Access
Knockoff procedure improves causal gene identifications in conditional transcriptome-wide association studies
Xiangyu Zhang, Lijun Wang, Jia Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Real-world evaluation of cardiometabolic outcomes with liraglutide and adjunctive therapies in type 2 diabetes
Saleem Qureshi, Hamna Ahmed, Mussarat Iqbal, et al.
(2025) Vol. 1, Iss. 1
Open Access
Use of glucagon‐like peptide‐1 receptor agonists and incretin mimetics for type 2 diabetes and obesity: A narrative review
Jason Zupec, R Munger, Alice L. Scaletta, et al.
Nutrition in Clinical Practice (2025)
Closed Access
Regulation of GLP-1 and Glucagon Receptor Function by β-Arrestins in Metabolically Important Cell Types
Liu Liu, Muhammad Rashid, Jürgen Wess
Biochemistry (2025)
Closed Access
Investigating the Role of Physical Activity and Exercise in Preventing Obesity and Type 2 Diabetes: A Mixed-Methods Approach
Syed Murad Ali Shah, Haris Riaz Khan, Tahira Sher Afghan, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 2, pp. 525-533
Closed Access
An overview of insulin therapy for the non‐specialist
Philip Home
Diabetes Obesity and Metabolism (2025)
Open Access
Effect of tirzepatide on weight and metabolism in a multiethnic cohort with and without diabetes
Sara El Ghandour, Fatemeh Akbarpoor, M. Malik, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management
Rahul Mittal, K. Mohana Prasad, Joana Lemos, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2320-2320
Open Access
Page 1 - Next Page

Scroll to top